Integrated proteins Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, revealing a challenging third quarter performance. The Gujarat-based company reported a net loss during the quarter, marking a significant shift from the profitable performance in the corresponding period of the previous year.

Financial Performance Overview

The company's quarterly performance showed notable deterioration across key metrics. The most striking aspect was the complete absence of operational revenue during the quarter, which significantly impacted overall profitability.

Nine-Month Performance Analysis

Despite the challenging third quarter, the nine-month performance presented a different picture. The company demonstrated substantial operational activity during the first half of the fiscal year.

Expense Structure and Operational Metrics

The company's expense profile during Q3FY26 remained minimal, reflecting the absence of operational activity. Total expenses for the quarter stood at ₹1.55 lakh, comprising primarily employee benefit expenses of ₹0.60 lakh and other expenses of ₹0.95 lakh. This contrasted with Q3FY25 expenses of ₹4.71 lakh.

For the nine-month period, the company incurred total expenses of ₹421.41 lakh, with purchases of stock-in-trade representing the largest component at ₹404.45 lakh. Employee benefit expenses totaled ₹2.62 lakh, while other expenses amounted to ₹14.35 lakh.

Capital Structure and Share Information

The company maintained a stable capital structure throughout the reporting period:

Fund Utilization and Corporate Actions

The company provided details regarding fund utilization from its preferential issue. The total amount raised was ₹1744.88 lakh through preferential issues conducted on multiple dates in January and February 2025. The funds were allocated for capital expenditure (₹1054.75 lakh) and exploring new initiatives (₹690.13 lakh), with the company reporting full utilization of the raised amount.

Board Meeting and Regulatory Compliance

The Board of Directors meeting was held on February 12, 2026, from 4:30 PM to 5:00 PM, where directors considered and approved the unaudited financial results. The results were reviewed by the Audit Committee before board approval and underwent limited review by statutory auditors B.B. Gusani & Associates, Chartered Accountants. The company confirmed compliance with Indian Accounting Standard 34 for interim financial reporting and SEBI listing regulations.

Integrated Proteins Limited has announced key changes in its management structure following a board meeting conducted on December 30, 2025. The company has accepted the resignation of its Company Secretary and appointed a replacement in the same role, as disclosed in its regulatory filing to BSE Limited.

Board Meeting Outcomes

The board of directors convened at the company's registered office on Tuesday, December 30, 2025, from 1:00 PM to 1:30 PM to address important personnel matters. The meeting resulted in two significant decisions regarding the Company Secretary and Compliance Officer position, conducted pursuant to Regulation 30 and Schedule III of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Resignation of Ms. Palak Chauhan

Ms. Palak Chauhan submitted her resignation from the position of Company Secretary and Compliance Officer, which was accepted by the board with effect from December 30, 2025. In her resignation letter dated December 30, 2025, Ms. Chauhan stated her intention to pursue an alternate career outside the organization.

Ms. Chauhan confirmed in her resignation letter that there were no material reasons for her departure other than her career decision. She expressed gratitude to the board of directors, senior management, and colleagues for their support during her tenure.

Appointment of Mr. Girish Kalwani

The board simultaneously approved the appointment of Mr. Girish Kalwani as the new Company Secretary and Compliance Officer, designated as Key Managerial Personnel effective December 31, 2025. Mr. Kalwani holds the qualification of Company Secretary with membership number A57701.

Professional Background

Mr. Kalwani brings relevant expertise to his new role as an Associate Member of the Institute of Company Secretaries of India. According to the company's disclosure, he is described as a highly motivated, detail-oriented professional with a strong academic foundation in corporate law, governance, and compliance.

Regulatory Compliance

The appointments and resignations were conducted in accordance with the provisions of Section 203 of the Companies Act 2013 and reported under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company has fulfilled all necessary disclosure requirements and will submit the required forms with the Registrar of Companies. The official communication was signed by Managing Director Karanj Dharmeshbhay and filed with BSE Limited at Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai.